Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as triamcinolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.
Type:
Grant
Filed:
October 28, 2020
Date of Patent:
November 29, 2022
Assignees:
NOVEL DRUG SOLUTIONS LLC, EYE CARE NORTHWEST, PA
Inventors:
Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Kuper
Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
Type:
Grant
Filed:
October 29, 2020
Date of Patent:
September 13, 2022
Assignees:
NOVEL DRUG SOLUTIONS LLC, PYP CAR NORTHWEST, PA
Inventors:
Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Peters
© 2024 Justia
